Two Sigma Investments’s Palisade Bio PALI Stock Holding History
Bought
Maintained
Sold
Other funds holding PALI
BGI
Two Sigma Investments's PALI Position: Q3 2026 in Review
Two Sigma Investments sold out of Palisade Bio (PALI) in Q3 2026, closing a stake of 126,602 shares — an estimated $265K sold.
Two Sigma Investments first reported a position in PALI in Q4 2021 and held it in 7 quarters. The position peaked at $265K in Q2 2026. 116 funds tracked by Wall St. Rank hold PALI as of Q3 2026.
- Two Sigma Investments reported no remaining Palisade Bio position as of Q3 2026 after selling out during the quarter.
- Two Sigma Investments sold 126,602 Palisade Bio shares in Q3 2026, an estimated $265K.
- Two Sigma Investments first reported a position in Palisade Bio in Q4 2021 and held it in 7 quarters.
- Two Sigma Investments's Palisade Bio position peaked at $265K in Q2 2026.
- 116 funds tracked by Wall St. Rank held Palisade Bio as of Q3 2026.
Based on Two Sigma Investments's 13F filing for Q3 2026, filed 16 Nov 2026.